COMOLLI, GIUDITTA
 Distribuzione geografica
Continente #
NA - Nord America 913
EU - Europa 648
AS - Asia 596
SA - Sud America 94
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.270
Nazione #
US - Stati Uniti d'America 882
CN - Cina 232
SG - Singapore 165
IT - Italia 164
RU - Federazione Russa 112
IE - Irlanda 103
HK - Hong Kong 96
DE - Germania 81
BR - Brasile 69
FI - Finlandia 59
VN - Vietnam 35
GB - Regno Unito 32
IN - India 19
SE - Svezia 18
PL - Polonia 16
CA - Canada 15
ZA - Sudafrica 11
BE - Belgio 10
FR - Francia 10
JP - Giappone 10
MX - Messico 10
ES - Italia 9
UA - Ucraina 9
VE - Venezuela 9
NL - Olanda 7
AT - Austria 6
IQ - Iraq 5
BD - Bangladesh 4
ID - Indonesia 4
LT - Lituania 4
PY - Paraguay 4
TR - Turchia 4
BH - Bahrain 3
CZ - Repubblica Ceca 3
AL - Albania 2
AR - Argentina 2
CL - Cile 2
EC - Ecuador 2
EG - Egitto 2
GE - Georgia 2
JM - Giamaica 2
KR - Corea 2
LB - Libano 2
LK - Sri Lanka 2
PE - Perù 2
SA - Arabia Saudita 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BZ - Belize 1
CG - Congo 1
CO - Colombia 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GY - Guiana 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MZ - Mozambico 1
PT - Portogallo 1
TG - Togo 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 2.270
Città #
Dallas 175
Dublin 99
Ashburn 98
Hong Kong 96
Singapore 96
Chandler 77
Beijing 74
New York 55
Munich 48
Milan 43
Helsinki 35
Pavia 34
Boardman 30
Los Angeles 30
Ann Arbor 26
Shanghai 24
Moscow 18
Nanjing 18
Turku 18
Redondo Beach 17
Princeton 16
Jacksonville 14
Lawrence 13
Orem 13
Wilmington 13
Buffalo 12
Warsaw 12
Rome 11
Seattle 11
Ho Chi Minh City 10
Medford 10
Poplar 10
Tokyo 10
Brooklyn 9
Brussels 8
Denver 8
Frankfurt am Main 8
Shenyang 8
Toronto 8
Chennai 7
Hebei 7
Johannesburg 7
Nanchang 7
Santa Clara 7
Stockholm 7
São Paulo 6
The Dalles 6
Amsterdam 5
Düsseldorf 5
Hanoi 5
San Francisco 5
Columbus 4
Corsico 4
Falls Church 4
Jinan 4
London 4
Mexico City 4
Piscataway 4
Pune 4
Belo Horizonte 3
Biên Hòa 3
Boston 3
Cascina 3
Changsha 3
Charlotte 3
Guangzhou 3
Haiphong 3
Hamad Town 3
Hangzhou 3
Houston 3
Jiaxing 3
Montreal 3
Tianjin 3
Vigevano 3
Washington 3
Annapolis 2
Atlanta 2
Bereguardo 2
Brescia 2
Buccinasco 2
Bulungan 2
Bắc Giang 2
Cairo 2
Chengdu 2
Chicago 2
Colombo 2
Guarulhos 2
Hyderabad 2
Jette 2
Kemerovo 2
Lauterbourg 2
Magé 2
Milwaukee 2
Montevideo 2
Mumbai 2
Nuremberg 2
Querétaro 2
Rio de Janeiro 2
Salvador 2
San Diego 2
Totale 1.519
Nome #
Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation 128
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 124
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 119
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 108
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 108
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. 102
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 102
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 94
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 93
Occult HIV infection in a large sample of health-care users in Lombardy, Italy in 2014-2015: Implications for control strategies 88
Human Cytomegalovirus-Specific Memory CD4+T-Cell Response and Its Correlation with Virus Transmission to the Fetus in Pregnant Women with Primary Infection 84
Dengue Virus-Specific Humoral and T Cellular Immune Response in Italian Residents and Travelers Returning from Endemic Areas 82
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 78
Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. 78
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 74
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 73
Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay 73
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 72
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 63
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 62
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 59
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy 58
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 57
Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis 55
Performance of new pp65-IGRA for the quantification of HCMV-specific CD4+ T-cell response in healthy subjects and in solid organ transplant recipients 55
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay 54
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up 52
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 46
Different Antigen-Specific CD4+ and CD8+ T-Cell Response against HCMV Proteins in Pregnant Women with Primary Infection and in Control Subjects with Remote Infection 32
Memory T cells specific for HBV enumerated by a peptide-based cultured enzyme-linked immunospot assay in healthy HBV-vaccinated subjects 30
Totale 2.303
Categoria #
all - tutte 12.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 2 2 13 5 4 6 1
2021/202294 3 2 2 2 4 4 7 8 1 12 9 40
2022/2023284 17 27 2 18 12 19 0 7 120 2 55 5
2023/2024258 24 34 11 9 13 82 26 17 1 8 17 16
2024/2025620 17 34 9 45 13 47 32 22 152 39 74 136
2025/2026869 104 113 209 185 185 73 0 0 0 0 0 0
Totale 2.303